CORONA Remedies Limited (NSE:CORONA)

CORONA Remedies Revenue

CORONA Remedies had revenue of 4.22B INR in the quarter ending June 30, 2026, with 21.90% growth. This brings the company's revenue in the last twelve months to 14.79B, up 19.24% year-over-year. In the fiscal year ending March 31, 2026, CORONA Remedies had annual revenue of 14.03B with 17.28% growth.

• Revenue (ttm): 14.79B
• Revenue Growth: +19.24%
• P/S Ratio: 8.74
• Revenue / Employee: 2.87M
• Employees: 5,153
• Market Cap: 129.24B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	14.03B	2.07B	17.28%
Mar 31, 2025	11.96B	1.82B	17.94%
Mar 31, 2024	10.14B	1.30B	14.75%
Mar 31, 2023	8.84B	2.67B	43.21%
Mar 31, 2022	6.17B	411.66M	7.14%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error